Hempstreet Medicare

HempStreet is India's first research-to-retail venture in the Ayurvedic cannabis sector, founded in 2019. The company develops and manufactures scientifically validated, cannabis-based Ayurvedic formulations to address mass ailments such as chronic pain, menstrual cramps (dysmenorrhea), anxiety, insomnia, and hypertension. HempStreet operates a B2B model, dispensing its GMP-certified, prescription-only products through a vast network of over 60,000 Ayurvedic practitioners and clinics across India. To ensure safety and prevent abuse, the company utilizes blockchain technology for end-to-end supply chain tracking. HempStreet is also actively engaged in clinical research, collaborating with institutions like the Council of Scientific and Industrial Research (CSIR) and international partners to validate its phytomedicine portfolio.